AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The FDA recently announced that the labeling of both Elidel (pimecrolimus) and Protopic (tacrolimus) will be updated to include a black box warning concerning a possible risk of cancer. In addition, a Medication Guide will be given to patients to warn them of this concern. The warning label will state that these medications should be used only as second line agents ...